• 1
    Glantz A, Lammert F, Mattson L A, Marschall H U. Intrahepatic cholestasis of pregnancy: results from the Swedish observation and intervention trials. XVIII International Bile Acid Meeting. Bile Acid Biology and its Therapeutic Implications. June 18–19, 2004, Stockhom (abstract).
  • 2
    Kroumpouzos G, Cohen L M. Specific dermatoses of pregnancy: an evidence-based systematic review. Am J Obstet Gynecol 2003; 188: 108392.
  • 3
    Savander M, Ropponen A, Avela K, et al. Genetic evidence of heterogeneity in intrahepatic cholestasis of pregnancy. Gut 2003; 52: 10259.
  • 4
    Reyes H, Gonzalez M C, Ribalta, et al. Prevalence of intrahepatic choletasis of pregnancy in Chile. Ann Intern Med 1978; 88: 48793.
  • 5
    Jacquemin E, Cresteil D, Manouvrier S, et al. Heterozygous nonsense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy. Lancet 1999; 353: 2101.
  • 6
    Rosmorduc O, Hermelin B, Poupon R. MDR3 defect in adults with symptomatic intrahepatic and gallbladder cholesterol cholelithiasis. Gastroenterology 2001; 120: 145967.
  • 7
    Gendrot C, Bacq Y, Brechot M C, et al. A second heterozygous MDR3 nonsense mutation associated with intrahepatic cholestasis of pregnancy. J Med Genet 2003; 40: 327.
  • 8
    Müllenbach R, Linton K J, Wiltshire S, et al. ABCB4 gene sequence variation in women with intrahepatic cholestasis of pregnancy. J Med Genet 2003; 40: 709.
  • 9
    Pauli-Magnus C, Lang T, Meier Y, et al. Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy. Pharmacogenetics 2004; 14: 91102.
  • 10
    Trauner M, Boyer J L. Bile salt transporters: molecular characterization, function and regulation. Physiol Rev 2003; 63371.
  • 11
    Serrano M A, Macias R I, Vallejo M, et al. Effect of ursodeoxycholic acid on the impairment induced by maternal cholestasis in the rat placenta-maternal liver tandem excretory pathway. J Pharmacol Exp Ther 2003; 305: 51524.